Quantitative Evaluation of Lymphoid Reaction and CD8+ T Lymphocyte Count in Colorectal Carcinoma (CRC) and Its Association with Grading and Staging of CRC

Author:

Lingutla Getha Rani1,Arakeri Surekha Ulhas2

Affiliation:

1. Department of Pathology, Bangalore Medical College, Bangalore, Karnataka, India

2. Department of Pathology, BLDE (Deemed to be University), Shri B M Patil Medical College, & Research Centre, Vijayapura, Karnataka, India

Abstract

Abstract Introduction: Staging of colorectal carcinoma (CRC) is based on the depth of tumor invasion, presence or absence of regional lymph node involvement, distant metastases, and differentiation. It was observed in some studies that an increase in lymphocytic infiltrate in CRC is linked with better survival. Hence, the present study was undertaken for quantitative evaluation of lymphoid reaction and CD8+T lymphocyte count in CRC. Aims and Objectives: To evaluate the association between peritumoral lymphoid reaction (PTLR) and CD8+T lymphocyte infiltration with grading and staging of CRC. Materials and Methods: A cross-sectional, descriptive study on excised specimens of CRC received in the Department of Pathology from 2015 to 2020 was done. A total of 38 resected specimens of CRC diagnosed as adenocarcinoma on histopathology were evaluated for age, sex, tumor location, grading, and staging of the tumor. A quantitative evaluation of PTLR and CD8+ T lymphocyte marker score was done in all cases and was correlated with the grading and staging of CRC. Results: The mean age of patients in the present study was 52.8 years with male-to-female ratio of 1:1. The most common site was the proximal colon. The majority of the cases were moderately differentiated adenocarcinoma. Stage pT3 and pNo were the most common followed by stage pT2 and stage pN1. PTLR and CD8+ lymphocyte count were highest in well-differentiated adenocarcinoma, in stage pT1 and stage pN0. Conclusions: Significant association was noted between PTLR and CD8+T lymphocyte count with grading and staging, and hence these can be considered as prognostic markers in CRC.

Publisher

Medknow

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3